AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 728,500 shares, an increase of 167.5% from the August 31st total of 272,300 shares. Based on an average daily trading volume, of 610,700 shares, the short-interest ratio is presently 1.2 days. Based on an average daily trading volume, of 610,700 shares, the short-interest ratio is presently 1.2 days.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
Institutional investors have recently bought and sold shares of the company. J.Safra Asset Management Corp acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at $48,000. Farther Finance Advisors LLC acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the first quarter valued at $189,000. Magnolia Private Wealth LLC boosted its position in AGF U.S. Market Neutral Anti-Beta Fund by 3.9% during the first quarter. Magnolia Private Wealth LLC now owns 18,629 shares of the company’s stock valued at $388,000 after purchasing an additional 700 shares during the last quarter. Ethos Financial Group LLC boosted its position in AGF U.S. Market Neutral Anti-Beta Fund by 24.7% during the second quarter. Ethos Financial Group LLC now owns 25,229 shares of the company’s stock valued at $446,000 after purchasing an additional 5,004 shares during the last quarter. Finally, L.M. Kohn & Company acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at $570,000.
AGF U.S. Market Neutral Anti-Beta Fund Stock Performance
BTAL opened at $15.65 on Friday. The stock has a market cap of $357.60 million, a price-to-earnings ratio of 17.67 and a beta of -0.51. AGF U.S. Market Neutral Anti-Beta Fund has a 1 year low of $15.30 and a 1 year high of $22.10. The stock has a fifty day moving average price of $16.21 and a 200 day moving average price of $18.08.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Read More
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Why is the Ex-Dividend Date Significant to Investors?
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Dividend Capture Strategy: What You Need to Know
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.